close

Blogs > Cannabis Law Blog

The Relationship Between FDA Regulations and Cannabis-Based Drug Patents

As already discussed in my earlier blog post here, patentability of cannabis-related inventions is well-settled, as the USPTO has been granting this type of patents for decades. As the FDA begins approving cannabis-based drug products, patent owners in this market space should pay careful attention to the interplay between FDA regulations and patents. Failure to consider the impact of FDA regulations and patent requirements can result in the loss of valuable exclusivity for their high market value products.

To learn more about special considerations for developing IP strategy for FDA-regulated drug products, read our blog on Thinking About Patents.